MBTN Announces Dr. Joh Evans Coleman as Featured Speaker at the 2026 Neuro‑Oncology Symposium

The Meningioma Brain Tumor Network, Inc. (MBTN) is proud to announce that Dr. Joh Evans Coleman, Founder and CEO of MBTN, will serve as a featured speaker at the upcoming Neuro‑Oncology Symposium hosted by the University of Arizona College of Medicine – Phoenix, HonorHealth, and Banner Health on October 17, 2026.

This year’s symposium brings together leading clinicians, researchers, and patient‑advocacy organizations to explore the latest innovations in brain and spine tumor diagnostics, treatments, and multidisciplinary care. Within this forward‑looking scientific program, Dr. Evans Coleman will deliver a powerful session titled:

“Living with a Brain Tumor — Patient and Family Perspectives”

As a meningioma brain tumor survivor‑thriver, nonprofit founder, and national advocate for patient‑centered neuro‑oncology, Dr. Evans Coleman brings a uniquely human lens to a field often dominated by clinical and research discourse. Her session will highlight:

• The lived realities of navigating a brain tumor diagnosis

• The emotional, cognitive, and physical challenges faced by survivors

• The critical role of family and care partner support systems

• Gaps in care that patients-survivors-thrivers experience across the treatment continuum

• Survivor‑Thriver centered strategies for improving quality of life

• The importance of advocacy, community, and equitable access to care

Dr. Evans Coleman’s work through MBTN has helped elevate survivor voices, expand public awareness, and strengthen community‑based support for individuals and families impacted by meningioma and other brain tumors. Her participation in this symposium underscores the growing recognition that patient experience is essential to advancing neuro‑oncology practice.

A Symposium Bridging Science, Innovation, and Humanity

The Neuro‑Oncology Symposium will convene at the Health Sciences Education Building in Phoenix, bringing together experts across neurosurgery, neuro‑oncology, radiation oncology, imaging, and survivorship care. While the event will spotlight cutting‑edge advancements in tumor diagnostics and treatment innovation, it also emphasizes the importance of multidisciplinary collaboration — including the voices of survivors and caregivers. Dr. Evans Coleman’s session ensures that the lived experience remains central to the conversation.

MBTN’s Commitment to Advocacy and Education

MBTN continues to expand its national footprint as a leader in survivor-thriver-centered education, advocacy, and community support. Events like the Neuro-Oncology Symposium strengthen MBTN’s mission to ensure every patient/survuvor-thriver, care partner, and family has access to knowledge, empowerment, and compassionate care.

MBTN celebrates Dr. Evans  Coleman’s ongoing leadership and invites supporters, clinicians, researchers, and community members to join this important event.